Сохранить в:
| Главный автор: | Mamoor, Shahan |
|---|---|
| Формат: | Recurso digital |
| Язык: | |
| Опубликовано: |
Zenodo
2026
|
| Online-ссылка: | https://doi.org/10.5281/zenodo.20180426 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Схожие документы
The mIR-302 cluster is silenced upon differentiation to the mechanosensory lineage.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
NLRP7 engagement in transformation and etiology of chronic disease.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: HOXB7.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP1R9A.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP1R9A.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: GALNT6.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: HOXB6.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
A comprehensive description of the circulating tumor cell: TM6SF1.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP6R1.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.
по: Mamoor, Shahan
Опубликовано: (2025)
по: Mamoor, Shahan
Опубликовано: (2025)
Androgen signaling has functions in lineage commitment in the human embryo.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Unbiased discovery of genes required for pluripotency: Terf1.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Major differences between HPV+ and HPV- head and neck cancer.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Disparate immune receptor control by p53 sufficient and p53 deficient cancers.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
An expression screen to identify genes important for trastuzumab resistance: Pax8-as1.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
An expression screen to identify genes important for trastuzumab resistance: Ccl19.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Casz1 mobilization during TE lineage specification from the pluripotent state in embryonic stem cells.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EIF4G1.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Gpr84 is a marker of the inflammatory bowel disease Crohn's Disease.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
An epigenetic module common to the T lymphocyte.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
A relationship between p53 and Braf in mammalian cells.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Fam234b is selectively activated during the first cell division of the human embryo.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Haglr, a HOXD antisense growth-associated long non-coding RNA with functions in lineage commitment in the human embryo.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Rip kinase expression during early development in humans.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Gasdermin activation during lineage specification in the human embryo.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
An expression screen to identify genes important for trastuzumab resistance: Meox2.
по: Mamoor, Shahan
Опубликовано: (2026)
по: Mamoor, Shahan
Опубликовано: (2026)
Схожие документы
-
The mIR-302 cluster is silenced upon differentiation to the mechanosensory lineage.
по: Mamoor, Shahan
Опубликовано: (2026) -
NLRP7 engagement in transformation and etiology of chronic disease.
по: Mamoor, Shahan
Опубликовано: (2025) -
Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
по: Mamoor, Shahan
Опубликовано: (2025) -
Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
по: Mamoor, Shahan
Опубликовано: (2025) -
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
по: Mamoor, Shahan
Опубликовано: (2025)